Alternative biomarkörer til immunterapi
Sammanfattning
The increasing use of immunotherapy in cases of metastatic cancer has revealed an urgent need for predictive biomarkers. Here, molecular imaging is presented as a unique candidate for the development of robust biomarkers for cancer immunotherapy.